Use of Anticancer Therapies and Economic Burden Near the End of Life in Japan: Results From Claims Database

In patients with cancer, aggressive treatment near the end of life (EOL) may decrease quality of life and increase medical costs. In this study, we examined the use of anticancer therapies near the EOL in Japan. METHODS: We used a commercial database of health insurance claims in Japan, to examine p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kajimoto, Yusuke, Honda, Kazunori, Nozawa, Kazuki, Mukai, Mineko, Teng, Lida, Igarashi, Ataru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166540/
https://www.ncbi.nlm.nih.gov/pubmed/36455173
http://dx.doi.org/10.1200/GO.22.00227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166540/
https://www.ncbi.nlm.nih.gov/pubmed/36455173
http://dx.doi.org/10.1200/GO.22.00227

Ejemplares similares